Management of myeloma with bisphosphonates

被引：18

作者：

Bataille, R

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1996年 / 334卷 / 08期

关键词：

D O I：

10.1056/NEJM199602223340810

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：529 / 530

页数：2

共 11 条

[1] MECHANISMS OF BONE-LESIONS IN MULTIPLE-MYELOMA [J].

BATAILLE, R ;

CHAPPARD, D ;

KLEIN, B .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :285-295

[2] RECRUITMENT OF NEW OSTEOBLASTS AND OSTEOCLASTS IS THE EARLIEST CRITICAL EVENT IN THE PATHOGENESIS OF HUMAN MULTIPLE-MYELOMA [J].

BATAILLE, R ;

CHAPPARD, D ;

MARCELLI, C ;

DESSAUW, P ;

BALDET, P ;

SANY, J ;

ALEXANDRE, C .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :62-66

[3] EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA [J].

BELCH, AR ;

BERGSAGEL, DE ;

WILSON, K ;

OREILLY, S ;

WILSON, J ;

SUTTON, D ;

PATER, J ;

JOHNSTON, D ;

ZEE, B .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1397-1402

[4] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].

Berenson, JR ;

Lichtenstein, A ;

Porter, L ;

Dimopoulos, MA ;

Bordoni, R ;

George, S ;

Lipton, A ;

Keller, A ;

Ballester, O ;

Kovacs, MJ ;

Blacklock, HA ;

Bell, R ;

Simeone, J ;

Reitsma, DJ ;

Heffernan, M ;

Seaman, J ;

Knight, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493

[5] SUBGROUP AND COST-BENEFIT-ANALYSIS OF THE FINNISH MULTICENTER TRIAL OF CLODRONATE IN MULTIPLE-MYELOMA [J].

LAAKSO, M ;

LAHTINEN, R ;

VIRKKUNEN, P ;

ELOMAA, I .

BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :725-729

[6] RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER TRIAL OF CLODRONATE IN MULTIPLE-MYELOMA [J].

LAHTINEN, R ;

LAAKSO, M ;

PALVA, I ;

VIRKKUNEN, P ;

ELOMAA, I .

LANCET, 1992, 340 (8827) :1049-1052

[7] EVIDENCE FOR SECRETION OF AN OSTEOCLAST STIMULATING FACTOR IN MYELOMA [J].

MUNDY, GR ;

RAISZ, LG ;

COOPER, RA ;

SCHECHTER, GP ;

SALMON, SE .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (20) :1041-1046

[8]

PASSERI G, 1994, J BONE MINER RES S1, V9, P230

[9]

RADL J, 1985, CANCER-AM CANCER SOC, V55, P1030, DOI 10.1002/1097-0142(19850301)55:5<1030::AID-CNCR2820550518>3.0.CO

[10]

2-Y

← 1 2 →